Adam Jacob Schoenfeld MD

PubMed

• 1 citations
  LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 P...
  Natasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, Rina Hui, Sofia Baka
  Journal of Thoracic Oncology. 2025-10-01
• Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free s...
  Alissa J Cooper, Edoardo Garbo, Andrea Arfe, Michael Conroy, Narek Shaverdian
  Cancer. 2025-09-15
• Allele-specific HLA LOH in solid tumors: distinct patterns by tumor type and potential prognostic relevance.
  Tomasz Sewastianik, Christian Roy, Michael V Gormally, Meagan Montesion, Patrick Halvey
  Journal for Immunotherapy of Cancer. 2025-09-09

Journal Articles

• Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung Cancers  
  Helena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
• Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane Complexes  
  Chapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
• Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...  
  Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010

Abstracts/Posters

• The CNS Germinoma Experience at UCSF from 1980 to 2010
  Schoenfeld A, Molinaro A, Banerjee A, Haas-Kogan D, Mueller S, 3rd International CNS Germ Cell Tumour Symposium, Cambridge, England, 2013

Lectures

• Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers. 
  2019 ASCO Annual Meeting - 6/1/2019